Idexx Laboratories (IDXX) Consolidated Net Income (2009 - 2026)

Idexx Laboratories' Consolidated Net Income history runs 18 years deep, the most recent figure standing at $278.4 million for Q1 2026.

• In Q1 2026, Consolidated Net Income rose 14.74% year-over-year to $278.4 million; the TTM figure through Mar 2026 stood at $1.1 billion (up 22.38% YoY), while the FY2025 annual figure was $1.1 billion, up 19.33% from the prior year.
• Consolidated Net Income was $278.4 million for Q1 2026 at Idexx Laboratories, up from $248.2 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $294.0 million in Q2 2025 to a low of $132.0 million in Q2 2022.
• Historically, Consolidated Net Income has averaged $220.6 million across 5 years, with a median of $216.1 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Consolidated Net Income plunged 34.86% in 2022, then soared 69.9% in 2023.
• A 5-year view of Consolidated Net Income shows it stood at $172.2 million in 2022, then climbed by 12.96% to $194.5 million in 2023, then increased by 11.12% to $216.1 million in 2024, then climbed by 14.82% to $248.2 million in 2025, then gained by 12.19% to $278.4 million in 2026.
• The last three Consolidated Net Income figures came in at $278.4 million (Q1 2026), $248.2 million (Q4 2025), and $274.6 million (Q3 2025), per Business Quant data.